Cargando…
Early lessons from schistosomiasis mass drug administration programs
Mass drug administration using praziquantel is the backbone of the current strategy for the control of schistosomiasis. As the theoretical plans have moved into practical application, certain challenges with this approach have surfaced, and it is likely that annual mass drug administration alone may...
Autor principal: | Secor, W. Evan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752026/ https://www.ncbi.nlm.nih.gov/pubmed/26937275 http://dx.doi.org/10.12688/f1000research.6826.1 |
Ejemplares similares
-
Toward Mass Drug Administration Stopping Criteria for Schistosoma mansoni Control Programs
por: Secor, W. Evan
Publicado: (2019) -
Lessons Learned in Conducting Mass Drug Administration for Schistosomiasis Control and Measuring Coverage in an Operational Research Setting
por: Binder, Sue, et al.
Publicado: (2020) -
When Should the Emphasis on Schistosomiasis Control Move to Elimination?
por: Secor, W. Evan, et al.
Publicado: (2018) -
Optimizing Delivery of Mass Drug Administration for Schistosomiasis
por: Friedman, Jennifer F.
Publicado: (2019) -
Persistent Hotspots in Schistosomiasis Consortium for Operational Research and Evaluation Studies for Gaining and Sustaining Control of Schistosomiasis after Four Years of Mass Drug Administration of Praziquantel
por: Kittur, Nupur, et al.
Publicado: (2019)